X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (6) 6
aged (4) 4
analysis (4) 4
female (4) 4
humans (4) 4
index medicus (4) 4
middle aged (4) 4
survival (4) 4
cancer (3) 3
chemotherapy (3) 3
clinical trials (3) 3
male (3) 3
metastasis (3) 3
patients (3) 3
5-fluorouracil (2) 2
adenocarcinoma (2) 2
adult (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer therapies (2) 2
care and treatment (2) 2
combination (2) 2
diarrhea (2) 2
docetaxel (2) 2
double-blind (2) 2
double-blind method (2) 2
latin american history (2) 2
leucovorin (2) 2
lymphatic system (2) 2
melanoma (2) 2
metastases (2) 2
motivation (2) 2
neoplasm metastasis (2) 2
neutropenia (2) 2
oxaliplatin (2) 2
phase-iii (2) 2
product development (2) 2
survival analysis (2) 2
treatment outcome (2) 2
tumors (2) 2
vomiting (2) 2
vomiting - chemically induced (2) 2
2nd-line chemotherapy (1) 1
3122 cancers (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
abridged index medicus (1) 1
acids (1) 1
administration, oral (1) 1
aged, 80 and over (1) 1
alanine (1) 1
alanine transaminase (1) 1
american history (1) 1
aminoglutethimide (1) 1
anastrozole (1) 1
androstadienes - administration & dosage (1) 1
androstadienes - adverse effects (1) 1
androstadienes - therapeutic use (1) 1
angiogenesis (1) 1
antiemetic (1) 1
antiemetic therapy (1) 1
antigens (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
aprepitant (1) 1
area studies (1) 1
aromatase inactivator (1) 1
aromatase inhibitors - administration & dosage (1) 1
aromatase inhibitors - adverse effects (1) 1
aromatase inhibitors - therapeutic use (1) 1
arthralgia (1) 1
authors, uruguayan (1) 1
bevacizumab (1) 1
biomarker (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
book reviews (1) 1
books (1) 1
breast neoplasm (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - pathology (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - adverse effects (1) 1
camptothecin - analogs & derivatives (1) 1
cancer patients (1) 1
carcinoma (1) 1
carcinoma, pancreatic ductal - drug therapy (1) 1
carcinoma, pancreatic ductal - mortality (1) 1
cetuximab (1) 1
chemotherapy-induced nausea and vomiting (1) 1
cisplatin (1) 1
cisplatin - adverse effects (1) 1
cisplatin - therapeutic use (1) 1
collected works (1) 1
colon cancer (1) 1
colonic neoplasms - diagnosis (1) 1
colonic neoplasms - drug therapy (1) 1
colonic neoplasms - immunology (1) 1
colorectal carcinoma (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10018, pp. 545 - 557
Summary Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with metastatic pancreatic ductal adenocarcinoma previously treated... 
Internal Medicine | PLUS GEMCITABINE | SURVIVAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | ADENOCARCINOMA | 2ND-LINE CHEMOTHERAPY | OXALIPLATIN | PEP02 | DOCETAXEL | CARCINOMA | FOLFIRI | Leucovorin - administration & dosage | Humans | Middle Aged | Male | Fatigue - chemically induced | Diarrhea - chemically induced | Pancreatic Neoplasms - drug therapy | Neoplasm Metastasis | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Camptothecin - administration & dosage | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Irinotecan | Vomiting - chemically induced | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Liposomes | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Pancreatic cancer | Leucovorin | Product development | Research institutes | Metastasis | Antineoplastic agents | Analysis | Antigens | Chemotherapy | Medical prognosis | Clinical trials | Drug dosages | Cancer therapies | Tumors | Adenocarcinoma | Slopes | Therapy | Gemcitabine | Toxicity | Metastases | Nanoparticles | Randomization | Motivation | Vomiting | Safety management | Toxic diseases | Neutropenia | Folinic acid | Lymphatic system | Medical treatment | Diarrhea | FDA approval | Survival | Patients | Acids | Equivalence | Interactive systems
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 11/2015, Volume 23, Issue 11, pp. 3281 - 3288
Journal Article
by Maio, Michele and Lewis, Karl and Demidov, Lev and Mandalà, Mario and Bondarenko, Igor and Ascierto, Paolo A and Herbert, Christopher and Mackiewicz, Andrzej and Rutkowski, Piotr and Guminski, Alexander and Goodman, Grant R and Simmons, Brian and Ye, Chenglin and Yan, Yibing and Schadendorf, Dirk and Cinat, Gabriela and Fein, Luis Enrique and Brown, Michael and Guminski, Alexander and Haydon, Andrew and Khattak, Adnan and McNeil, Catriona and Parente, Phillip and Power, Jeremy and Roberts-Thomson, Rachel and Sandhu, Shahneen and Underhill, Craig and Varma, Suresh and Berger, Thomas and Awada, Ahmad and Blockx, Nathalie and Buyse, Veronique and Mebis, Jeroen and Franke, Fábio André and Jobim de Azevedo, Sérgio and Silva Lazaretti, Nicolas and Jamal, Rahima and Mihalcioiu, Catalin and Petrella, Teresa and Savage, Kerry and Song, Xinni and Wong, Ralph and Dabelic, Nina and Plestina, Stjepko and Vojnovic, Zeljko and Arenberger, Petr and Kocak, Ivo and Krajsova, Ivana and Kubala, Eugen and Melichar, Bohuslav and Vantuchova, Yvetta and Putnik, Kadri and Dreno, Brigitte and Dutriaux, Caroline and Grob, Jean-Jacques and Joly, Pascal and Lacour, Jean-Philippe and Meyer, Nicolas and Mortier, Laurent and Thomas, Luc and Fluck, Michael and Gambichler, Thilo and Hassel, Jessica and Hauschild, Axel and Schadendorf, Dirk and Donnellan, Paul and McCaffrey, John and Power, Derek and Ariad, Samuel and Bar-Sela, Gil and Hendler, Daniel and Ron, Ilan and Schachter, Jacob and Ascierto, Paolo and Berruti, Alfredo and Bianchi, Luca and Chiarion Sileni, Vanna and Cognetti, Francesco and Danielli, Riccardo and Di Giacomo, Anna Maria and Gianni, Luca and Goldhirsch, Aron and Guida, Michele and Maio, Michele and Mandalà, Mario and Marchetti, Paolo and Queirolo, Paola and Santoro, Armando and Kapiteijn, Ellen and Mackiewicz, Andrzej and Rutkowski, Piotr and Ferreira, Paula and Demidov, Lev and Gafton, Georgy and Makarova, Yulia and Andric, Zoran and Babovic, Nada and Jovanovic, Darjana and Kandolf Sekulovic, Lidija and Cohen, Graham and ... and BRIM8 Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 510 - 520
Background: Systemic adjuvant treatment might mitigate the high risk of disease recurrence in patients with resected stage IIC–III melanoma. The BRIM8 study... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2017, Volume 35, Issue 18_suppl, pp. LBA3 - LBA3
LBA3 Background: Pts with newly diagnosed mHNPC, particularly with high-risk characteristics, have a poor prognosis. ADT+docetaxel showed improved outcomes in... 
Journal Article
by Fuchs, Charles S and Shitara, Kohei and Di Bartolomeo, Maria and Lonardi, Sara and Al-Batran, Salah-Eddin and Van Cutsem, Eric and Ilson, David H and Alsina, Maria and Chau, Ian and Lacy, Jill and Ducreux, Michel and Mendez, Guillermo Ariel and Alavez, Alejandro Molina and Takahari, Daisuke and Mansoor, Wasat and Enzinger, Peter C and Gorbounova, Vera and Wainberg, Zev A and Hegewisch-Becker, Susanna and Ferry, David and Lin, Ji and Carlesi, Roberto and Das, Mayukh and Shah, Manish A and Luft, Alexander V and Karaseva, Nina A and Kowalyszyn, Rubén Dario and Hernandez, Carlos Alberto and Csoszi, Tibor and De Vita, Ferdinando and Pfeiffer, Per and Sugimoto, Naotoshi and Kocsis, Judit and Csilla, Andràs and Bodoky, Gyorgy and Garnica Jaliffe, Georgina and Protsenko, Svetlana and Madi, Ayman and Wojcik, Elzbieta and Brenner, Baruch and Folprecht, Gunnar and Sarosiek, Tomasz and Peltola, Katriina Johanna and Bono, Peter and Ayala, Hubert and Aprile, Giuseppe and Gerardo, Cardellino Giovanni and Huitzil Melendez, Fidel David and Falcone, Alfredo and Di Costanzo, Francesco and Tehfe, Moustapha and Mineur, Laurent and García Alfonso, Pilar and Obermannova, Radka and Senellart, Hélène and Petty, Russell and Samuel, Leslie and Acs, Peter Istvan and Hussein, Maen Abdelkarim and Nechaeva, Marina N and Erdkamp, F.L.G and Won, Elizabeth and Bendell, Johanna Chock and Gallego Plazas, Javier and Lorenzen, Sylvie and Melichar, Bohuslav and Escudero, Miguel Angel and Pezet, Denis and Phelip, Jean-Marc and Kaen, Diego Lucas and Reeves, James A. Jr and Longo Muñoz, Federico and Madhusudan, Srinivasan and Barone, Carlo and Fein, Luis Enrique and Gomez Villanueva, Angel and Hebbar, Mohamed and Prausova, Jana and Visa Turmo, Laura and Vidal Barrull, Joana and Yilmaz, Mette Karen Nytoft and Beny, Alex and Van Laarhoven, H.M.W and DiCarlo, Brian Anthony and Esaki, Taito and Fujitani, Kazumasa and Geboes, Karen and Geva, Ravit and Kadowaki, Shigenori and Leong, Stephen and Machida, Nozomu and Raj, Moses Sundar and Ramirez Godinez, Francisco Javier and Ruzsa, Agnes and Ford, Hugo and Lawler, William E and Maisey, Nicolas Robert and Petera, Jiri and Shacham-Shmueli, Einat and Sinapi, Isabelle and ... and RAINFALL Study Grp and RAINFALL Study Group
The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. 420 - 435
VEGF and VEGF receptor 2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression of gastric cancer. We aimed to... 
EXPOSURE-RESPONSE | MULTICENTER | GASTROESOPHAGEAL JUNCTION | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | COMBINATION | CANCER | EXPRESSION | CHEMOTHERAPY | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma | Antimitotic agents | Care and treatment | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Rain and rainfall
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 182 - 182
182 Background: AA + P added to androgen deprivation therapy (ADT) improves overall survival (OS) in newly diagnosed mCNPC patients (pts). AA has been... 
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2019, Volume 30, Issue 5, pp. 766 - 773
Abstract Background Pertuzumab combined with trastuzumab and docetaxel is the standard first-line therapy for HER2-positive metastatic breast cancer, based on... 
paclitaxel | first line | pertuzumab | dual HER2 blockade | HER2-positive | metastatic breast cancer | WEEKLY PACLITAXEL | ONCOLOGY | NAB-PACLITAXEL | PROGRESSION-FREE SURVIVAL | DOCETAXEL
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2000, Volume 18, Issue 7, pp. 1399 - 1411
Purpose: This phase ill, double-blind, randomized, multicenter study evaluated the efficacy, pharmacodynamics, and safety of the oral aromatase inactivator... 
ONCOLOGY | HORMONAL TREATMENT | STEROIDAL AROMATASE INHIBITOR | AMINOGLUTETHIMIDE | ENDOCRINE | ANASTROZOLE
Journal Article
by Maio, Michele and Lewis, Karl and Demidov, Lev and Mandalà, Mario and Bondarenko, Igor and Ascierto, Paolo and Ascierto, Paolo A and Herbert, Christopher and Mackiewicz, Andrzej and Rutkowski, Piotr and Guminski, Alexander and Goodman, Grant R and Simmons, Brian and Ye, Chenglin and Yan, Yibing and Schadendorf, Dirk and Cinat, Gabriela and Fein, Luis Enrique and Brown, Michael and Brown, Ewan and Haydon, Andrew and Khattak, Adnan and McNeil, Catriona and Parente, Phillip and Power, Derek and Power, Jeremy and Roberts-Thomson, Rachel and Sandhu, Shahneen and Underhill, Craig and Varma, Suresh and Berger, Thomas and Awada, Ahmad and Blockx, Nathalie and Buyse, Veronique and Mebis, Jeroen and Franke, Fábio André and Jobim de Azevedo, Sérgio and Silva Lazaretti, Nicolas and Jamal, Rahima and Mihalcioiu, Catalin and Petrella, Teresa and Savage, Kerry and Song, Xinni and Wong, Ralph and Dabelic, Nina and Plestina, Stjepko and Vojnovic, Zeljko and Arenberger, Petr and Kocak, Ivo and Krajsova, Ivana and Kubala, Eugen and Melichar, Bohuslav and Vantuchova, Yvetta and Putnik, Kadri and Dreno, Brigitte and Dutriaux, Caroline and Grob, Jean-Jacques and Joly, Pascal and Lacour, Jean-Philippe and Meyer, Nicolas and Mortier, Laurent and Thomas, Luc and Fluck, Michael and Gambichler, Thilo and Hassel, Jessica and Hauschild, Axel and Donnellan, Paul and McCaffrey, John and Ariad, Samuel and Bar-Sela, Gil and Hendler, Daniel and Ron, Ilan and Schachter, Jacob and Berruti, Alfredo and Bianchi, Luca and Chiarion Sileni, Vanna and Cognetti, Francesco and Danielli, Riccardo and Di Giacomo, Anna Maria and Gianni, Luca and Goldhirsch, Aron and Guida, Michele and Marchetti, Paolo and Queirolo, Paola and Santoro, Armando and Kapiteijn, Ellen and Ferreira, Paula and Gafton, Georgy and Makarova, Yulia and Andric, Zoran and Babovic, Nada and Jovanovic, Darjana and Kandolf Sekulovic, Lidija and Cohen, Graham and Dreosti, Lydia and Vorobiof, Daniel and Curiel Garcia, Maria Teresa and Diaz Beveridge, Roberto and Majem Tarruella, Margarita and Marquez Rodas, Ivan and ...
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 510 - 520
Systemic adjuvant treatment might mitigate the high risk of disease recurrence in patients with resected stage IIC–III melanoma. The BRIM8 study evaluated... 
Journal Article
by Maio, Michele and Lewis, Karl and Demidov, Lev and Mandala, Mario and Bondarenko, Igor and Ascierto, Paolo A and Herbert, Christopher and Mackiewicz, Andrzej and Rutkowski, Piotr and Guminski, Alexander and Goodman, Grant R and Simmons, Brian and Ye, Chenglin and Yan, Yibing and Schadendorf, Dirk and Cinat, Gabriela and Fein, Luis Enrique and Brown, Michael and Haydon, Andrew and Khattak, Adnan and McNeil, Catriona and Parente, Phillip and Power, Jeremy and Roberts-Thomson, Rachel and Sandhu, Shahneen and Underhill, Craig and Varma, Suresh and Berger, Thomas and Awada, Ahmad and Blockx, Nathalie and Buyse, Veronique and Mebis, Jeroen and Franke, Fabio Andre and Jobim de Azevedo, Sergio and Silva Lazaretti, Nicolas and Jamal, Rahima and Mihalcioiu, Catalin and Petrella, Teresa and Savage, Kerry and Song, Xinni and Wong, Ralph and Dabelic, Nina and Plestina, Stjepko and Vojnovic, Zeljko and Arenberger, Petr and Kocak, Ivo and Krajsova, Ivana and Kubala, Eugen and Melichar, Bohuslav and Vantuchova, Yvetta and Putnik, Kadri and Dreno, Brigitte and Dutriaux, Caroline and Grob, Jean-Jacques and Joly, Pascal and Lacour, Jean-Philippe and Meyer, Nicolas and Mortier, Laurent and Thomas, Luc and Fluck, Michael and Gambichler, Thilo and Hassel, Jessica and Hauschild, Axel and Donnellan, Paul and McCaffrey, John and Power, Derek and Ariad, Samuel and Bar-Sela, Gil and Hendler, Daniel and Ron, Ilan and Schachter, Jacob and Ascierto, Paolo and Berruti, Alfredo and Bianchi, Luca and Chiarion Sileni, Vanna and Cognetti, Francesco and Danielli, Riccardo and Di Giacomo, Anna Maria and Gianni, Luca and Goldhirsch, Aron and Guida, Michele and Marchetti, Paolo and Queirolo, Paola and Santoro, Armando and Kapiteijn, Ellen and Ferreira, Paula and Gafton, Georgy and Makarova, Yulia and Andric, Zoran and Babovic, Nada and Jovanovic, Darjana and Kandolf Sekulovic, Lidija and Cohen, Graham and Dreosti, Lydia and Vorobiof, Daniel and Curiel Garcia, Maria Teresa and Diaz Beveridge, Roberto and Majem Tarruella, Margarita and Marquez Rodas, Ivan and Puliats Rodriguez, Jose-M and ...
Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, p. 510
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/S1470-2045(18)30106-2... 
Analysis | Melanoma | Clinical trials | Genetic aspects
Journal Article
by Emile, Jean-François and Julié, Catherine and Le Malicot, Karine and Lepage, Come and Tabernero, Josep and Mini, Enrico and Folprecht, Gunnar and Van Laethem, Jean-Luc and Dimet, Stéphanie and Boulagnon-Rombi, Camille and Allard, Marc-Antoine and Penault-Llorca, Frédérique and Bennouna, Jaafar and Laurent-Puig, Pierre and Taieb, Julien and Thaler, Josef and Greil, Richard and Gaenzer, Johannes and Eisterer, Wolfgang and Tschmelitsch, Joerg and Keil, Felix and Samonigg, Hellmut and Zabernigg, August and Schmid, Franz and Steger, Günther and Steinacher, Robert and Andel, Johannes and Jagdt, Björn and Lang, Alois and Fridrik, Michael and Függer, Reinhold and Hofbauer, Friedrich and Woell, Ewald and Geissler, Michael and Geissler, Dietmar and Lenauer, Alfred and Prager, Manfred and D'Haens, Geert and Demolin, Gauthier and Kerger, Joseph and Deboever, Guido and Ghillebert, Gilbert and Polus, Marc and Van Cutsem, Eric and Kalantari, Hassan Rezaie and Delaunoit, Thierry and Goeminne, Jean Charles and Peeters, Marc and Vergauwe, Philippe and Houbiers, Ghislain and Humblet, Yves and Janssens, Jos and Schrijvers, Dirk and Vanderstraeten, Erik and Vermorken, Jan and Van Daele, Daniel and Ferrante, Michel and Forget, Frederic and Hendlisz, Alain and Yilmaz, Mette and Nielsen, Svend Erik and Vestermark, Lene and Larsen, Jim and Zawadi, Mohamed-Ayman and Bouche, Olivier and Mineur, Laurent and Bennouna-Louridi, Jaafar and Dourthe, Louis Marie and Ychou, Marc and Boucher, Eveline and Pezet, Denis and Desseigne, Francoise and Ducreux, Michel and Texereau, Patrick and Miglianico, Laurent and Rougier, Philippe and Fratte, Serge and Levache, Charles-Briac and Merrouche, Yacine and Ellis, Stephen and Locher, Christophe and Ramee, Jean-Francois and Garnier, Claire and Viret, Frederic and Chauffert, Bruno and Cojean-Zelek, Isabelle and Michel, Pierre and Lecaille, Cedric and Borel, Christian and Seitz, Jean-Francois and Smith, Denis and Lombard-Bohas, Catherine and Andre, Thierry and Gornet, Jean-Marc and Fein, Francine and Coulon-Sfairi, Marie-Aude and Kaminsky, Marie-Christine and Lagasse, Jean-Paul and Luet, Dominique and Etienne, Pierre-Luc and ... and PETACC8 Study Investigators and Istituto Oncologico Romagnolo (IOR) and Fédération Nationale des Centres de Lutte Contre le Cancer Association Européenne de Recherche en Oncologie (AERO) and Gruppo Cooperativo do Cancro Digestivo da Associação Portuguesa de Investigação Oncológica (GCCD, APIO) and Lone Nørgård Petersen and Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente (GISCAD) and Austrian Breast and Colorectal cancer Study Group (ABCSG) and Belgian Group of Digestive Oncology (BGDO) and Gruppo Cooperativo Chirurgico Italiano (GOCCI) and John Allen Bridgewater and Gruppo Oncologico dell'Italia Meridionale (GOIM) and Fédération Francophone de Cancérologie Digestive (FFCD) and Gruppo Oncologico Nord Ovest (GONO) and Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER) and Grupo Español para el Tratamiento de los Tumores Digestivos (TTD) and Arbeitsgemeinschaft Internistische Onkologie (AIO) and Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
European Journal of Cancer, ISSN 0959-8049, 09/2017, Volume 82, pp. 16 - 24
Journal Article